TECregen AG

TECregen AG is a pioneering force in biotechnology research, focused on developing innovative solutions in immuno-rejuvenation. TECregen is dedicated to advancing next-generation therapies specifically designed to regenerate the thymus, aiming to enhance immune function and overall health. The company operates with a commitment to scientific excellence and the development of groundbreaking treatments.

Located at Hochbergerstrasse 60C, Basel, 4057, CH, TECregen AG combines cutting-edge research with a strategic vision for improving patient outcomes. TECregen is poised to make significant contributions to the field of regenerative medicine through its dedicated efforts and forward-thinking approach.

TECregen AG is actively working to expand its research initiatives and bring transformative therapies to market. We invite the management of TECregen AG to create a customized and exclusive company showcase and product listing on our platform, allowing you to further highlight your advancements and connect with a wider audience.